Category: Medical Technology

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

Global Community Report Banner photo FSPLogoGlobalCommunityFulloldworldmapbckgrnd_zps43d3059c.jpg






The Telegraph

First genetically modified humans could exist within two years

Biotech company Editas Medicine is planning to start human trials to genetically edit genes and reverse blindness

Humans who have had their DNA genetically modified could exist within two years after a private biotech company announced plans to start the first trials into a ground-breaking new technique.

Editas Medicine, which is based in the US, said it plans to become the first lab in the world to ‘genetically edit’ the DNA of patients suffering from a genetic condition – in this case the blinding disorder ‘leber congenital amaurosis’.

The disorder prevents normal function of the retina; the light-sensitive layer of cells at the back of the eye. It appears at birth or in the first months of life and eventually sufferers can go completely blind.

“Hereditary eye disease in an obvious place to start given that there is already precedent in classical gene therapy”
Professor Darren Griffin, University of Kent

The rare inherited disease is caused by defects in a gene which instructs the creation of a protein that is essential to vision.

But scientists at Editas Medicine in the US believe they can fix the mutated DNA using the ground-breaking gene-editing technology Crispr.

Katrine Bosley, the chief executive of Editas Medicine, told a conference in the US that the company hopes to start trialling the technology on blind patients in 2017.

It would be the first time the technology has been used on humans. Gene editing is currently banned in the US, so the company would need special permission from health regulators.

“It feels fast, but we are going at the pace science allows,” Bosley told the EmTech conference in Cambridge, Massachusetts.


Read More Here

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg



Following on the heels of Angelina Jolie’s widely celebrated decision to remove her breasts ‘preventively,’ few truly understand how important preventing environmental chemical exposures and incorporating cancer-preventing foods into their diet really is in reducing the risk of gene-mediated breast cancer.  

There is so much fear and misinformation surrounding the so-called ‘Breast Cancer Associated’ genes, BRCA1 and BRCA2, that it should help to dispel some prevailing myths by looking at the crucial role that epigenetic factors play in their expression.  Literally ‘above’ (epi) or ‘beyond’ the control of the genes, these factors include environmental chemical exposures, nutrition and stress, which profoundly affect cancer risk within us all, regardless of what variant (‘mutated’ or ‘wild’)* that we happen to carry within our genomes.

In 2012, a very important study was published in the Journal of Nutritional Biochemistry that looked at the role a natural compound called resveratrol may play in preventing the inactivation of the BRCA-1 gene. BRCA-1 is known as a “caretaker” gene because it is responsible for healing up double-strand breaks within our DNA. When the BRCA-1 gene is rendered dysfunctional or becomes inactivated, either through a congenital/germline inheritance of DNA defects (‘mutation’) or through chemical exposures, the result is the same: harm to the DNA repair mechanisms within the affected cells (particularly breast and ovary; possibly testicular), hence increasing the risk of cancer.

Ironically, while the prevalence of a “bad” inherited BRCA1 variation is actually quite low relative to the general population (A 2003 study found only 6.6% of breast cancer patients even have either a BRCA1 and BRCA2 germline mutation[1]), everyone’s BRCA1 and BRCA2 genes are susceptible to damage from environmental chemical exposures, most particularly xenobiotic (non-natural) chemicals and radiation. This means that instead of looking to a set of “bad” genes as the primary cause of cancer, we should be looking to avoid exposing both our “bad” and “good” genes alike to preventable chemical exposures, as well as avoiding nutrient deficiencies and/or incompatibilities, which also play a vital role in enabling us to express or silence cancer-associated genes. [For more on why genes don’t “cause” disease see: The Great DNA Data Deficit.]


8 Pink Foods that Fight Breast Cancer

There are plenty of “pink” products in support of breast cancer awareness, but why not just cut out the middle man and eat naturally pink anti-breast cancer foods?

It’s Breast Cancer Awareness Month, when companies love to showcase pink packaging…but sometimes, what’s inside those packages isn’t so healthy. So we’ve rounded up 8 naturally pink foods that have all been shown to help keep away breast cancer. Always choose organic to avoid pesticides and toxins. Go, Mother Nature!

Red cabbage


A compound called indole-3-carbinol (also rich in cruciferous vegetables) is now being researched for its potential to significantly reduce the incidence of breast cancer.



These gem-like fruits may prevent breast cancer, lab studies suggest, by blocking a certain enzyme (aromatase) that converts androgen to estrogen.



Extract of red beetroot has been shown to help suppress multi-organ tumors in lab tests, and experts are considering using them in combination with traditional anticancer drugs to reduce their toxic side effects.



High in antioxidants, these have been shown to help reduce the spread of breast cancer cells. Additionally, a lab study with Japanese radish sprouts significantly lowered the incidence of mammary tumors.


Read More Here



Research: Ginger Selectively Kills Breast Cancer Cells

Research: Ginger Selectively Kills Breast Cancer Cells

New research published in the Journal of Biomedicine and Biotechnology found that “ginger may be a promising candidate for the treatment of breast carcinomas.”[i]  This is a timely finding, insofar as breast cancer awareness month is only days away, and one of the primary fund-raising justifications is the false concept that a low-cost, safe and effective breast cancer treatment is not yet available. Could ginger provide the type of cure that conventional, FDA-approved treatments have yet to accomplish?

The new study was performed by researchers at the Biological Sciences Department, Faculty of Sciences, King Abdulaziz University, Saudi Arabia, who discovered that a crude extract derived from the medicinal plant ginger (Zingiber officinale) inhibited the proliferation of breast cancer cells, without significantly affecting the viability of non-tumor breast cells — a highly promising property known as selective cytotoxicity, not found in conventional treatments.

The researchers outline the serious problems with present breast cancer therapies thusly:

Despite significant advances toward targeted therapy and screening techniques, breast cancer continues to be a chronic medical problem worldwide, being the most common type of cancer in women and the leading cause of death [1]. Typically, the treatment of breast cancer involves hormonal therapy with tamoxifen or other selective estrogen receptor (ER) modulators [24]. However, almost all patients with metastatic disease and approximately 40% of patients that receive tamoxifen experience relapse that ends by death [5]. In addition, the clinical utility of ER antagonists is often limited by side effects [2, 3, 6] and is largely ineffective against ER-negative breast cancer [2, 3]. Furthermore, despite the fact that many tumors initially respond to chemotherapy, breast cancer cells can subsequently survive and gain resistance to the treatment [7]. Thus, identification of novel agents that are relatively safe but can suppress growth of both ER-positive and ER-negative human breast cancers is highly desirable.

They described their interest in investigating crude extracts of ginger in the following manner:

Despite knowledge about the potent anticancer activity of the ginger, the molecular mechanisms underlying this activity are not currently well known in breast cancer. Based on the previously mentioned reported scientific data and considering the fact that in some cases herbal extracts are showing more potency than the purified components [21, 22], the present study was undertaken to investigate the impacts of crude extracts of ginger on growth of breast cancer cell lines.

They discovered that ginger was capable of positively modulating a surprisingly wide range of molecular mechanisms simultaneously, such as:

  • Induction of apoptosis (programmed cell death)
  • Upregulation of Bax (a pro-apoptosis gene)
  • Downregulation of Bcl-2 proteins (cancer-associated)
  • Downregulation of prosurvival genes NF-κB, Bcl-X, Mcl-1, and Survivin
  • Downregulation of cell cycle-regulating proteins, including cyclin D1 and cyclin-dependent kinase-4 (CDK-4). (cancer-associated)
  • Increased expression of CDK inhibitor, p21 (anti-cancer associated)
  • Inhibition of c-Myc, hTERT (cancer-associated)

Eating Flaxseed May Reduce Breast Cancer Mortality By Up To 70%

Flaxseeds Reduce Breast Cancer Mortality By Up To 70%

Mainstream medicine continues to push women to get yearly mammograms as a way to defend themselves against the epidemic of deadly breast cancer.  However, mammograms do nothing to prevent the disease or improve survival rates. But the amazing little flaxseed does.

Scores of studies reveal the anticancer effects of flaxseed. Researchers from the University of Toronto recently reviewed the literature to answer questions about the compounds found in flaxseed and how effective they are in reducing breast cancer risk and tumor growth, and whether flaxseeds interact beneficially with breast cancer drugs.

They reviewed in vitro, animal, observational, and clinical studies on flaxseed and flaxseed oil, as well as lignans found in flaxseed.

Lignans are a class of phytoestrogens or plant estrogens that also act as antioxidants. Other foods also contain lignans including sesame, sunflower and pumpkin seeds, grains (rye, barley, wheat and oats), broccoli and beans.   But flaxseed has hundreds of times the amount of lignans as any of the others.

The University of Toronto review documents the amazing power of flaxseed to prevent and slow the growth of breast cancer.   Here’s what the studies tell us:

  • The majority of animal studies show a diet of 2.5%-10% flaxseed or the equivalent amount of lignan or flaxseed oil reduces tumor growth.
  • Diets consisting of 10% flaxseed and the equivalent amount of lignans do not interfere with but rather increase the effectiveness of tamoxifen.  A diet of 4% flaxseed oil increases trastuzumab/Herceptin effectiveness.
  • Observational studies show flaxseed and lignan intake, urinary excretion, or serum levels are associated with reduced breast cancer risk, particularly in postmenopausal women.
  • Lignans reduce breast cancer mortality by 33% to 70%.  They also reduce all-cause mortality by 40%-53%.  In both cases, lignans do not reduce the effectiveness of Tamoxifen.
  • Clinical trials show that taking 25 grams per day of flaxseed (containing 50 mg lignans) for 32 days reduces tumor growth in breast cancer patients.
  • Taking 50 mg of lignans for one year reduces breast cancer risk in premenopausal women.

Flaxseeds protect women from breast cancer in a variety of ways.  Here are just a few:

  1. Flaxseeds decrease tumor cell proliferation.  When eaten, lignans in flaxseeds are broken down by bacteria in the gut into 2 estrogen-like compounds that circulate through the liver. These compounds have been proven in animal studies to help prevent breast cancer by preventing tumor growth.
  2. Lignans block tumor blood supply.  Tumors need angiogenesis – new blood vessels – to supply oxygen and nutrients for growth.  Flaxseeds inhibit the growth factor needed to stimulate angiogenesis according to animal studies.
  3. Lignans lower estrogen production. Lignans block aromatase, the enzyme involved in the production of estrogen.  Blocking the enzyme lowers estrogen production.  High estrogen levels have been linked to the growth of breast cancer.


Read More Here




Turmeric Extract Strikes To The Root Cause of Cancer Malignancy

A new turmeric study published in Cancer Letters is paving the way for a revolution in the way that we both understand and treat cancer. Titled, “Targeting cancer stem cells by curcumin and clinical applications,” U.S. researchers evaluated the primary polyphenol in the Indian spice known as curcumin for its ability to target cancer stem cells (CSCs), which are believed to be at the root cause of tumor formation and malignancy.

Whereas conventional models of cancer assumed that the majority of the cancer cells within a tumor possess self-renewal capacity to differing degrees, the CSC model proposes that, “[T]he initiation, maintenance, and growth of a tumor is driven by a minor population of cancer cells termed cancer stem cells (CSCs),” and that “These CSCs undergo continuous self-renewal and differentiate to heterogeneous cancer cells, yielding new tumors recapitulating the parental tumors, while the majority of cancer cells lack self-renewal capacity.”

In other words, the CSCs are at the apex of a hierarchy of cells within the tumor, and are the “mother” of the various daughter cells that make it up, most of which are intrinsically benign. Conventional treatment with chemotherapy and radiotherapy, based on a rodent model with a 2-year experimental window to evaluate treatment efficacy and safety, was incapable of comprehending the CSC-mediated cause of post-treatment tumor recurrence, which in humans can take decades after initial treatment to manifest. Although it was possible to debulk a tumor with surgery, chemotherapy and radiation, CSC populations were often missed or even enriched as a result. When the tumor mass regrew it often became more invasive and treatment-resistant, resulting in the rapid demise and death of the patient — deaths which are often written off inaccurately or disingenuously as non-treatment related.

Given that conventional treatment can drive an intrinsically benign tumor (i.e., so-called indolent tumors) into greater invasiveness through increasing the number of intrinsically resilient cancer stem cells at the very same moment that it kills the less or non-harmful daughter cells, alternative treatment approaches are needed now more than ever.


Read More Here



Research: Curcumin Is A Triple Negative Breast Cancer Killer

Research: Curcumin Is A Triple Negative Breast Cancer Killer

A new study from Zheijian Provincial People’s Hospital in Zheijiang, China indicates that a compound in turmeric known as curcumin, which gives the spice its characteristic saffron-like color, is capable of inducing programmed cell death (apoptosis) within triple negative breast cancer cells.1

Triple negative breast cancer (TNBC), so named because the cells do not have the characteristic receptors for estrogen, progesterone and Her2/neu, is considered the most treatment resistant, primarily because these ‘missing receptors’ are required for many of the most popular conventional treatments to work, e.g. Tamoxifen targets estrogen receptors. For this reason, TNBC is considered the most aggressive, the most likely to be treated with less-targeted (and therefore more toxic) forms of chemotherapy, and the soonest to return when treatment fails.

Approximately 15-25% of all breast cancer cases are triple negative. Unfortunately, however, the most visible non-profit foundation dedicated to bringing awareness to the condition, the Triple Negative Breast Cancer Foundation, is focused almost exclusively on raising awareness and money for a future pharmaceutical “cure”  – much in the same way as its partner, Susan G. Komen, and the larger breast cancer awareness organization, Breast Cancer Awareness Month, act as if removing and addressing the obvious causes of cancer, e.g. carcinogenic chemical and radiation exposures, were not the first priority.  For those suffering through or recovering from treatment right now, or trying to decide what to do with a new diagnosis, this latest Chinese study is promising.


Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg



NaturalNews's profile photo



(NaturalNews) In a refreshing change of pace, an established doctor has shed light on the fact that many mainstream medical approaches designed to improve health aren’t what they’re cracked up to be. In fact, they’re downright ineffective.

While this hardly comes as a surprise when you consider the plethora of side effects that come with pharmaceuticals, and that they alter the minds of those who take them, what is surprising is that a medical professional has boldly dared to come forward to publicly expose a medical scam.

Dr. Dwight Lundell, a heart surgeon and retired Chief of Staff and Chief of Surgery at Banner Heart Hospital in Mesa, Arizona, has made no qualms about pharmaceuticals’ ineffectiveness and the need to let go of commonly held medical beliefs. In particular, he’s put statins in the spotlight, saying that the cholesterol-lowering drugs wreak havoc on health.(1)

Heart surgeon: Current heart health methods and recommendations “not working”

His comment deserves reading:

As a heart surgeon with 25 years experience… today is my day to right the wrong with medical and scientific fact.

I trained for many years with other prominent physicians labeled “opinion makers.” Bombarded with scientific literature, continually attending education seminars, we opinion makers insisted heart disease resulted from the simple fact of elevated blood cholesterol. The only accepted therapy was prescribing medications to lower cholesterol and a diet that severely restricted fat intake. The latter of course we insisted would lower cholesterol and heart disease. Deviations from these recommendations were considered heresy and could quite possibly result in malpractice. It Is Not Working!

These recommendations are no longer scientifically or morally defensible.(1)

His thought-provoking statements reinforce what many have believed all along: The conventional medical system is not working. Yet ties to deep pockets and behind-the-scenes ulterior business motives – which are common in the mainstream medical world – keep the industry going. The business of sickness is a profitable one.

For example, statin drugs recently came under even more scrutiny than normal after scientists at Tulane University in New Orleans produced more evidence that they are far from healthy. It was determined that they accelerate the aging process, render many of the body’s cells unable to carry out essential functions and can lead to liver dysfunction, memory loss, cataracts and diabetes.(2)

Lying for profit: Telling healthy people they are anything but

Heart health and the pharmaceutical inadequacies surrounding it aren’t the only medical issues coming under fire. When it comes to cancer, chemotherapy-for-profit scams abound. Sadly, there are many bad apples in the medical bunch who think it’s acceptable to tell healthy people that they have cancer when they don’t, even going so far as to administer treatments.

One such doctor is Michigan oncologist Dr. Farid Fata, who pleaded guilty to 16 counts of healthcare fraud and misdiagnosing patients. He repeatedly misinformed patients that they needed chemotherapy when they did not. Some family members of his patients even noted a sense of desperation; one son recalls the time his father was met by Dr. Fata’s staff curbside, at which point they proceeded to give his deteriorating father treatments as he sat in his car in a parking garage.(3)

Not so pretty in pink: Cancer scams also a disgrace

The cancer scams have long-been a disgrace to society, with the Susan G. Komen for the Cure foundation at the forefront of such deceit and wrongdoing. As reported by alternative media sites, their partnerships with mammogram manufacturers and pharma companies mean – guess what – it’s not really your health, but the financial partnerships they’ve forged, that truly matter. All of that, tied up in a neat little pink bow and perhaps a matching pink shirt to match, to make you feel good about donating to a cause.(4)

Then there’s the whole debacle with mammograms. While women flock to them in droves based on the ingrained (brainwashed?) belief that they’re life-saving devices, the reality is that many times the method fails to properly differentiate between invasive and non-invasive cancers. As such, many women undergo energy-zapping, drawn-out procedures that forever alter their health, or even lead to their death.(5)

So, kudos to Dr. Dwight Lundell for speaking up.

Everyone deserves good health, not false promises and scams that create the opposite effect.

Sources for this article include:







About NaturalNews

The NaturalNews Network is a non-profit collection of public education websites covering topics that empower individuals to make positive changes in their health, environmental sensitivity, consumer choices and informed skepticism. The NaturalNews Network is owned and operated by Truth Publishing International, Ltd., a Taiwan corporation. It is not recognized as a 501(c)3 non-profit in the United States, but it operates without a profit incentive, and its key writer, Mike Adams, receives absolutely no payment for his time, articles or books other than reimbursement for items purchased in order to conduct product reviews.

The vast majority of our content is freely given away at no charge. We offer thousands of articles and dozens of downloadable reports and guides (like the Honest Food Guide) that are designed to educate and empower individuals, families and communities so that they may experience improved health, awareness and life fulfillment.

Learn More About Natural News Here

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg


What we think we know about the BRCA (Breast Cancer Susceptibility Associated) genes causing cancer is patently false, according to a new meta-analysis on the extant literature on the subject of these gene variations on breast cancer survival prognosis.  

A groundbreaking new meta-analysis published in PLoS titled,”Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What’s the Evidence? A Systematic Review with Meta-Analysis“, calls into question the value of using BRCA1/2 gene status to determine breast cancer survival prognosis, as is common practice today. This implications of this research may have wide-ranging effects as the present climate, following Angelina Jolie’s high profile decision to have prophylactic breast, ovary and fallopian tube removed due to her perceived “genetic inheritance,” is to equate BRCA status with bona fide and mathematically calculable disease risk certainty.

Jolie’s decision to subject herself to multiple prophylactic organ removal was based on the premise that her BRCA mutations would result in an 87 percent lifetime risk of developing breast cancer and up to 54 percent chance of ovarian cancer, as prognosticated by her doctors. The notion that BRCA genes have full or near full penetrance (the ability of a mutation to cause clinically identifiable disease) has profound implications for the health of millions of women who rely on these predictions to make life and death medical decisions.

Because of a wide range of conflicting conclusions on the subject of BRCA’s role in determining cancer risk and prognosis, researchers in the new study attempted a systematic and quantitative synthesis of evidence using the following method:

“Eligible publications were observational studies assessing the survival of breast cancer patients carrying a BRCA1/2 mutation compared to non-carriers or the general breast cancer population. We performed meta-analyses and best-evidence syntheses for survival outcomes taking into account study quality assessed by selection bias, misclassification bias and confounding.”

They summarized their findings:

“Our review shows that, in contrast to currently held beliefs of many oncologists and despite 66 published studies, it is not yet possible to draw evidence-based conclusions about the association between BRCA1 and/or BRCA2 mutation carriership and breast cancer prognosis. We only found sufficient evidence for a 10% worse unadjusted recurrence-free survival for BRCA1 mutation carriers. For all the other outcomes the evidence was judged to be indecisive.”

In their concluding remarks, the researchers state, “In contrast to currently held beliefs of some oncologists, current evidence does not support worse breast cancer survival of BRCA1/2 mutation carriers in the adjuvant setting; differences if any are likely to be small. More well-designed studies are awaited.”

Read More Here

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg


NaturalNews's profile photo

(NaturalNews) Remember the Ebola outbreak of 2014 when nurses infected with Ebola were proclaimed “cured” through the intervention of pharmaceutical medicine? Like everything else the MSM broadcast about Ebola, we now know it was all a sinister fabrication.

Texas nurse Nina Pham was widely celebrated as a hero by the mainstream media for her role in treating an infected Ebola patient that started an outbreak in a Dallas hospital. What the media didn’t tell you is that Nina Pham was nearly killed by the Ebola “treatment” medicines administered by the hospital. “Nina Pham, the first known case of an individual contracting Ebola within the U.S., is now suing the parent corporation of her former employer, which she says violated her personal privacy and left her chronically ill by exploiting and neglecting her during the outbreak,” Natural News reported earlier this year.

“The 26-year-old nurse says she now suffers from constant nightmares, body aches and insomnia due to the experimental medications that were forced upon her while in isolation.”

Pharmaceutical interventions, in other words, caused serious organ damage to nurse Pham, and that damage is permanent. Naturally, the CDC-controlled media exploited Pham for P.R. purposes, but once the news had passed, they left her permanently damaged and abandoned by the system.

A second nurse is also in serious health trouble due to toxic Ebola treatments

Now reported in The Independent (UK): “A British nurse who was apparently cured of Ebola earlier this year is now in a critical condition, doctors have said, with experts expressing astonishment at the deterioration of her condition.”

Pauline Cafferkey was admitted to the specialist treatment isolation unit at Royal Free Hospital in London on 9 October. She had been treated for Ebola at the same hospital earlier this year, and was discharged in good health in January.

None of us here at Natural News are surprised, of course. We’ve long known that everything the medical establishment says about Ebola is a deliberate lie, and that includes pharmaceutical Ebola “treatment” promises.

“The exact nature of Ms Cafferkey’s illness is not known, but experts have expressed shock at the severity of her condition,” reports The Independent.

Here’s what’s really going on: In exactly the same way that AIDS drugs destroy the human immune system and cause symptoms of AIDS, Ebola drugs also destroy the patient’s body and cause critical organ failure.

This fundamental truth about the toxicity of Big Pharma’s deadly drugs will never be admitted in the pharma-controlled press.

Same system that pushes toxic pharmaceutical treatments viciously attacks colloidal silver

As you ponder all this, keep in mind that all holistic treatments for Ebola were viciously and aggressively attacked by governments and the media during the Ebola outbreak. Those who offered colloidal silver treatments or products were threatened by U.S. regulators and mocked by the media… even though colloidal silver is a non-toxic treatment that cannot cause the kind of organ failure we’re witnessing from pharmaceutical interventions.

Non-profits such as Dr. Rima Laibow’s Natural Solutions Foundation were even viciously threatened by the IRS after Dr. Laibow began talking about colloidal silver as a non-toxic treatment option. (No doubt the CDC pressured the IRS to target the NSF in the same way the IRS targets liberty-oriented non-profits.)

“The IRS sent us a warning letter saying that by sharing US Department of Defense Threat Reduction Agency declassified research on the impact of our particular Nano Silver 10 PPM on the ability of the Ebola virus to cause disease we had miraculously turned the substance into a drug,” Dr. Laibow told Natural News. “We responded to them in detail (26 pages, if I recall properly) and they sent back another letter backing off a bit but demanding changes in our site.”

Meanwhile, companies that sold high-grade medicinal essential oils such as doTerra were threatened by government regulators with being put out of business if they didn’t police their independent distributors who were sharing the true news that many essential oils can kill Ebola.

The medical system, government and media essentially invoked an all-out WAR on natural medicine while claiming their own pharmaceuticals were the only safe treatments for Ebola. Now we see just what a farce those claims really were. Much like chemotherapy, the “treatment” for Ebola may be just as deadly as Ebola itself.

Meanwhile, all the truly SAFE treatments like colloidal silver have been intentionally disparaged, marginalized and pushed to the fringes of alternative medicine. It’s no coincidence that colloidal silver can’t be patented and is universally available for mere pennies, thereby threatening the more important aspect of Big Pharma’s disease pandemic schemes: PROFITS!

Here at Natural News, our prayers go out to Pauline Cafferkey with the hope that she won’t end up as yet another needless victim of Big Pharma’s toxic treatments and the mainstream media’s outrageous lies that misled medical staff into falsely believing that pharmaceutical treatments for Ebola are safe.

Sources for this article include:………


About NaturalNews

The NaturalNews Network is a non-profit collection of public education websites covering topics that empower individuals to make positive changes in their health, environmental sensitivity, consumer choices and informed skepticism. The NaturalNews Network is owned and operated by Truth Publishing International, Ltd., a Taiwan corporation. It is not recognized as a 501(c)3 non-profit in the United States, but it operates without a profit incentive, and its key writer, Mike Adams, receives absolutely no payment for his time, articles or books other than reimbursement for items purchased in order to conduct product reviews.

The vast majority of our content is freely given away at no charge. We offer thousands of articles and dozens of downloadable reports and guides (like the Honest Food Guide) that are designed to educate and empower individuals, families and communities so that they may experience improved health, awareness and life fulfillment.

Learn More About Natural News Here


NBC News

Ebola Virus Outbreak
Oct 13 2014, 4:51 pm ET

Who is Nina Pham? Meet the Nurse Who Contracted Ebola

This undated photo made available by the Antwerp Institute of Tropical Medicine in Antwerp, Belgium, shows the Ebola virus viewed through an electron microscope. Antwerp Institute of Tropical Me / AP

Nina Pham is the nurse who contracted the Ebola virus and is being treated in Dallas, a close family friend has confirmed to NBC News Monday.

Pham is the first patient to contract the disease while on U.S. soil, according to the Centers for Disease Control and Prevention, which said the transmission resulted from an unknown “breach of protocol” in treating Thomas Eric Duncan when he returned to Texas Presbyterian a second time. On Monday CDC director Tom Frieden clarified that he in no way meant to place blame on the stricken nurse.

“This is a very brave person who put herself at risk to do something good for society, and is now ill,” he said.

Dallas Nurse with Ebola is Clinically-Stable, says CDC4:38

Pham, 26, is a 2010 graduate of the Bachelors of Science in Nursing program at Texas Christian University, according to Lisa Albert, a spokesperson for the school. The four-year program prepares nurses to serve as “liaisons among doctors, patients and other members of the health care team,” according to the school website.

There is not a stand-alone course on infections disease work, but infection prevention strategies are “woven throughout all clinical coursework,” according to Albert. Precautionary methods are introduced at the start of clinical course work, reviewed through the curriculum, and students sign an end-of-semester document attesting to this work.

Pham was certified by the Texas Board of Nursing in 2010, according to state records, but she didn’t receive her certificate in Critical Care Nursing until Aug. 1 — less than two months before Duncan arrived at Texas Health Presbyterian critically ill with Ebola. Duncan died last week.

Read More Here




Ebola nurse Nina Pham files lawsuit against Texas Health Resources

Nurse Nina Pham, who contracted Ebola while caring for a patient at Texas Health Presbyterian Hospital Dallas, filed a lawsuit Monday in Dallas County against the hospital’s parent company, Texas Health Resources.

The lawsuit alleges that while she became the American face of the fight against the disease, the hospital’s lack of training and proper equipment and violations of her privacy made her “a symbol of corporate neglect — a casualty of a hospital system’s failure to prepare for a known and impending medical crisis.”

Shortly after the lawsuit was filed, Pham released a brief statement: “I was hoping that THR would be more open and honest about everything that happened at the hospital, and the things they didn’t do that led to me getting infected with Ebola. But that didn’t happen and I felt I was left with no choice but to turn to the courts for help. The fact is, I’m facing a number of issues with regard to my health and my career and the lawsuit provides a way to address them. But more importantly, it will help uncover the truth of what happened, and educate all health care providers and administrators about ways to be better prepared for the next public health emergency.  I particularly want to express my continued sympathy to the family of Mr. Duncan, as it was my privilege to care for him.  I also want to acknowledge my fellow nurses, and the many friends, family and strangers for their ongoing concern and support.”

Pham told The Dallas Morning News that Texas Health Resources was negligent because it failed to develop policies and train its staff for treating Ebola patients. She says Texas Health Resources did not have proper protective gear for those who treated Thomas Eric Duncan, the first person in the United State diagnosed with the disease. He died Oct. 8.

“I wanted to believe that they would have my back and take care of me, but they just haven’t risen to the occasion,” Pham said in the interview.


Read More Here



By Jennifer Emily | Staff Writer

Nina Pham claims the extent of her Ebola training was a printout of guidelines her supervisor found on the web. “The only thing I knew about Ebola, I learned in nursing school” six years earlier, Pham said.

Nina Pham claims the extent of her Ebola training was a printout of guidelines her supervisor found on the web. “The only thing I knew about Ebola, I learned in nursing school” six years earlier, Pham said.

Patients first

“I was proud of us. We fought in the trenches together, the frontline health care workers. That’s what nursing is about: putting the patient first. We did what we had to do,” Pham said.

She remembers spending hours alone with Duncan cleaning up his bodily fluids, monitoring his vital signs and reassuring him that everything would be OK. Pham said Duncan was in a great deal of pain and frightened but always polite. He told her “he felt very isolated.” She held his hand and told him she would pray for him.

But when Duncan tested positive for Ebola, it sent panic and fear throughout Presbyterian — and the nation. Pham, too, was frightened.

“I was the last person besides Mr. Duncan to find out he was positive,” she said. “You’d think the primary nurse would be the first to know. … I broke down and cried, not because I thought I had it but just because it was a big ‘whoa, this is really happening’ moment.”

Duncan, who contracted the disease in his native Liberia, died Oct. 8. A few days later, Pham tested positive for the disease. She was initially treated at Presbyterian and then the National Institutes of Health in Maryland with a series of experimental drugs and plasma from Dr. Kent Brantly, an Ebola survivor.

She says that Texas Health Resources violated her privacy while she was a patient at Presbyterian by ignoring her request that “no information” be released about her. She said a doctor recorded her on video in her hospital room and released it to the public without her permission.

Charla Aldous, Pham’s attorney, put it more simply: Texas Health Resources “used Nina as a PR pawn.”

Pham said she considered not going back to care for Duncan after his diagnosis. Her colleagues said they wouldn’t blame her for not returning to her job where normal 12-hour shifts had stretched to 14 or 15. Even her mother said she didn’t care if Pham lost her job.

Pham said that while she did not volunteer to care for Duncan, she felt that she couldn’t say no.

“I had a duty to take care of him,” she said. “It’s not in my nature to refuse.”


Read More Here

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg


Study Finds Women Still Suffering 3 Years After Breast Cancer False-Positive

Millions of women undergo them annually, but few are even remotely aware of just how many dangers they are exposing themselves to in the name of prevention, not the least of which are misdiagnosis, overdiagnosis and the promotion of breast cancer itself. 

A new study published in the Annals of Family Medicine titled, Long-term psychosocial consequences of false-positive screening mammography, brings to the forefront a major underreported harm of breast screening programs: the very real and lasting trauma associated with a false-positive diagnosis of breast cancer.[1]

The study found that women with false-positive diagnoses of breast cancer, even three years after being declared free of cancer, “consistently reported greater negative psychosocial consequences compared with women who had normal findings in all 12 psychosocial outcomes.”

The psychosocial and existential parameters adversely affected were:

  • Sense of dejection
  • Anxiety
  • Negative impact on behavior
  • Negative impact on sleep
  • Degree of breast self-examination
  • Negative impact on sexuality
  • Feeling of attractiveness
  • Ability to keep ‘mind off things’
  • Worries about breast cancer
  • Inner calm
  • Social network
  • Existential values

What is even more concerning is that “[S]ix months after final diagnosis, women with false-positive findings reported changes in existential values and inner calmness as great as those reported by women with a diagnosis of breast cancer.”

In other words, even after being “cleared of cancer,” the measurable adverse psychospiritual effects of the trauma of diagnosis were equivalent to actually having breast cancer.

Given that the cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography is at least 50%,[2] this is an issue that will affect the health of millions of women undergoing routine breast screening.

Read More Here

Global Community Report Banner photo FSPLogoGlobalCommunityFulloldworldmapbckgrnd_zps43d3059c.jpg

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg


© Baz Ratner
Ebola cases in Sierra Leone could have been cut by 50 percent had the UK had set up beds in the stricken nation’s treatment centers just one month earlier, a new report claims.

Researchers at the London School of Hygiene and Tropical Medicine (LSHTM) suggest had British aid efforts been provided sooner, some 7,500 people could have been prevented from contracting the virus.

During that time frame the UK installed more than 1,500 treatment beds in community centers, and a further 1,200 in specialist Ebola centers.

The World Health Organization (WHO) says 13,945 people fell ill between September 2014 and February 2015.

LSHTM lecturer in infectious diseases Dr Adam Kucharski and his colleagues say the UK’s involvement saved 40,000 lives. However more deaths could have been prevented had they intervened sooner.

View image on Twitter

Ebola nurse Pauline Cafferkey admitted to hospital ‘in a very serious condition’ 

Prostate cancer tests underestimate aggressiveness of disease, says study


A surgeon sitting in front of screens of a Focal One device performs a prostate tumorectomy.

A surgeon sitting in front of screens of a Focal One device performs a robot-assisted prostate tumorectomy. Photograph: Jeff Pachoud/AFP/Getty Images

Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, according to a study.

Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined later turned out to have more dangerous tumours.

The findings, published in the British Journal of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.

It also casts doubt on the “active surveillance” strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.

Instead, these patients are closely monitored but left alone until tests suggest their condition has worsened.

Urological surgeon Greg Shaw, from the Cancer Research UK Cambridge Institute, said: “Our results show that the severity of up to half of men’s prostate cancers may be underestimated when relying on tests before they have surgery.”

Slow-growing prostate cancers, known as “pussycats”, are very different from the more aggressive “tiger” variety.

In some cases, especially when he is older when diagnosed, a patient can live to the end of his normal life span before a “pussycat” cancer becomes a threat.

An aggressive “tiger”, on the other hand, may quickly spread if it is not surgically removed or destroyed.

Biopsy samples examined under a microscope are used to rate prostate tumour aggressiveness with a score ranging from two to 10. A score of between two and six is a low-grade “pussycat”. A score of seven is intermediate, while scores of eight to 10 are high-grade “tigers”.

Tumours are also staged according to how far they have spread. A T2 tumour is contained completely inside the prostate gland, while a T3 tumour has started to break out, and one classified T4 has spread to other organs or sites in the pelvic cavity.

The Cambridge scientists compared the staging and grading of more than 800 men’s cancers before and after they had surgery to remove their prostate.

They found that of 415 patients whose cancer was classified as slow-growing and confined to the prostate, just over half (209) were found to have a more aggressive disease than originally thought when assessed after surgery.


Read More Here

Enhanced by Zemanta


young sick Americans Living Sick and Dying Young in Rich America


Health Impact News Editor Comments

When I read an article in The Atlantic recently with the title: Living Sick and Dying Young in Rich America – Chronic illness is the new first-world problem – it caught my attention. This is the kind of topic we cover on a regular basis here at Health Impact News, but seldom do you read about it in the mainstream media.

There are 3 things that are rather astonishing about the sad state of health in America today:

1. We’re sicker than previous generations, and most of us know it.

2. We don’t seem to care about it too much. It is not headline news.

3. There doesn’t seem to be much motivation to change this fact: it seems to have been accepted as the new “norm.”

Last year, we reported about a study funded by the government and your tax dollars which clearly showed that the United States ranks #1 on healthcare spending, but last in life expectancy among wealthy nations (See: U.S. Ranks First in Healthcare Spending – Last in Life Expectancy). The mainstream media barely even covered this story, and even here at Health Impact News it was probably not even in the top 100 stories read from everything we published last year.

The sad fact seems to be that most Americans have adopted an attitude that the current health situation in the U.S. cannot be changed.

For those few of you who have not drunk the Kool Aid, and still believe you do have control over your health and have choices you can make to live a healthier life, then this article by John Thomas identifying the problems and solutions is for you.

Please understand that if enough Americans understand that the healthcare system (which is not really a “healthcare” system at all but a MEDICAL system) is the primary problem and take measures to avoid it, that it would absolutely destroy our economy, since so much of it is dependent on sick people. But maybe our economy is heading for destruction anyway, so don’t let that threat stop you from making healthy choices today.

Is it Normal to be Sick?

by John P. Thomas

Is it normal to be sick? Many people think so, but it hasn’t always been this way. What was life like before we became dependent on modern pharmaceutical drugs, major medical centers, and health insurance? If we turn back the clock a hundred and fifty years, we will hardly find anything that looks like the modern medical system. Did previous generations live in the dark ages of medicine, or is the modern age of chronic degenerative illness and modern pharmaceutical drugs actually a dark age of medicine?

I remember overhearing a conversation while waiting for a table in a restaurant some 25 years ago. A grandmother was talking to her 10 year old grandson. She must not have seen him for a while, so she began by asking one of those general types of questions to get the conversation started. “How are you feeling?” Without hesitation, her grandson started discussing his various health problems, which included allergies, asthma, fatigue, etc. In a grandmotherly voice filled with sympathy and concern, she gave a reply that sticks in my mind to this day.  She said, “I understand — we all have something wrong with us.” She went on to tell him that we are all sick and we have to learn to live with it. I don’t know if her words were entirely true then, but they are most certainly true today! We are sick and getting sicker, and we are all being taught to live with it.

Here we are 25 years later and despite all the medical and pharmaceutical advances that have taken place in the United States, we are sicker than ever. How many people do you know who are not taking one or more prescription medications? How many people do you know who do not have a medical diagnosis for some chronic illness? How many people do you know who are not being treated for some condition that requires periodic trips to the doctor to monitor disease progression and to adjust medications? How many people do you know who struggle with paying for medications? If I count the people I know, who do not fall into the groups I just mentioned, I can count them on the fingers of one hand. How about the people you know?

The purpose of this article is to examine how we respond to our illnesses and to questions whether our pharmaceutical drugs and system of healthcare is making us sicker than we need to be.

Does the Healthcare System in the United States Lead the World?

We certainly lead the world in the amount of dollars spent on healthcare. We spend 2.5 times more per person per year than is spent in any other country on Earth for healthcare.1

Does the Money we Spend for Healthcare Make Us the Healthiest people in the World?

The New York Times recently revealed how our healthcare system compares to other countries.

“In the Social Progress Index, the United States excels in access to advanced education but ranks 70th in health, 69th in ecosystem sustainability, 39th in basic education, 34th in access to water and sanitation and 31st in personal safety.”2

The United States is sitting in the 70th position down from the top of the list for the category of health when compared to other countries. Let’s look at the details of how we compare to other wealthy countries.

The Panel on Understanding Cross-National Health Differences Among High-Income Countries, compared the health of people living in the United States with people living in other high income countries, which included Australia, Austria, Canada, Denmark, Finland, France, Germany, Italy, Japan, Norway, Portugal, Spain, Sweden, Switzerland, the Netherlands, and the United Kingdom. They reported:

Over this time period, we uncovered a strikingly consistent and pervasive pattern of higher mortality and inferior health in the United States, beginning at birth: … For many years, Americans have had a shorter life expectancy than people in almost all of the peer countries. For example, as of 2007, U.S. males lived 3.7 fewer years than Swiss males and U.S. females lived 5.2 fewer years than Japanese females.3

We have the most expensive healthcare system in the world, which should make us the healthiest people on Earth, but this is not the case.

Why are We so Sick?….


Read More Here

Enhanced by Zemanta

Human-animal hybrids, disasters in the making

Human-animal hybrids, disasters in the making

Scientists worldwide are creating bizarre human-animal hybrids that could wreak havoc on society. In the past ten years alone, unforgettable advances in the field of genetic modifications have left researchers and on-lookers stunned.

Nowadays, it is possible for a couple of university-age students to concoct new life forms in the comfort of their own basement. Regrettably so, laws have not been able to keep up with the pace at which scientists have been toying around with their creations.

In turn, the entities being created are not at all illegal but by all means could pose a risk to society by and large. There is no telling what may happen if these life forms are allowed to mate. Still, eagerness can be seen in the eyes and minds of scientists on a global level just waiting to unleash their next creation to the world, that all seemed liked fantasy just a short time ago.

To give a concrete example, scientists have made mice with an artificial human chromosome “in every cell of their bodies”. Such an act is being praised as a “breakthrough” which may lead to different cures for a wide scope of disease. As reported by, University of Wisconsin researchers have had much success by transferring cells from human embryos into the brains of mice. These very cells began to grow, and in time made the mice more intelligent.

The mice showed that they were able to solve a simple maze and learn conditioning signals at a more enhanced level than if compared to before their transformation. Critics are quick to question whether a practice of injecting parts of humans in animals carries more benefits than risks.


Read More Here

Enhanced by Zemanta

Get every new post delivered to your Inbox.

Join 2,187 other followers